Your browser doesn't support javascript.
loading
Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination.
Hagan, Liesl M; Kasradze, Ana; Salyer, Stephanie J; Gamkrelidze, Amiran; Alkhazashvili, Maia; Chanturia, Gvantsa; Chitadze, Nazibrola; Sukhiashvili, Roena; Shakhnazarova, Marina; Russell, Steven; Blanton, Curtis; Kuchukhidze, Giorgi; Baliashvili, Davit; Hariri, Susan; Ko, Stephen; Imnadze, Paata; Drobeniuc, Jan; Morgan, Juliette; Averhoff, Francisco.
Affiliation
  • Hagan LM; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA. vqf8@cdc.gov.
  • Kasradze A; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Salyer SJ; Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Gamkrelidze A; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Alkhazashvili M; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Chanturia G; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Chitadze N; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Sukhiashvili R; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Shakhnazarova M; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Russell S; Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Blanton C; Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Kuchukhidze G; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Baliashvili D; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Hariri S; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Ko S; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Imnadze P; School of Public Health, Boston University, Boston, MA, USA.
  • Drobeniuc J; National Center for Disease Control and Public Health, Tbilisi, Georgia.
  • Morgan J; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Averhoff F; Division of Global Health Protection, Centers for Disease Control and Prevention, Atlanta, GA, USA.
BMC Public Health ; 19(Suppl 3): 480, 2019 May 10.
Article in En | MEDLINE | ID: mdl-32326913

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mass Screening / Hepatitis C / Hepacivirus / Disease Eradication Type of study: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: BMC Public Health Journal subject: SAUDE PUBLICA Year: 2019 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mass Screening / Hepatitis C / Hepacivirus / Disease Eradication Type of study: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: BMC Public Health Journal subject: SAUDE PUBLICA Year: 2019 Document type: Article Affiliation country: